Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

6.24
+0.640011.43%
Post-market: 6.19-0.0500-0.80%19:59 EDT
Volume:9.22M
Turnover:54.96M
Market Cap:1.00B
PE:-5.06
High:6.32
Open:5.40
Low:5.33
Close:5.60
Loading ...

These Stocks and ETFs Jump Against the Market Plunge on Friday

Tiger Newspress
·
11 hours ago

The FDA Is Being Gutted. 'People Are Going to Die.' -- Barrons.com

Dow Jones
·
16 hours ago

Novavax’s Regulatory Uncertainty and Market Potential: Hold Rating Maintained

TIPRANKS
·
Yesterday

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Yesterday

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

Yahoo Finance
·
Yesterday

Small to Mid-Cap Biotechnology Firms Likely to Continue to Face Macro Headwinds, BofA Securities Says

MT Newswires Live
·
03 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

Stock Track | Novavax Plummets 9.78% as FDA Misses Crucial COVID-19 Vaccine Decision Deadline

Stock Track
·
03 Apr

Stock Track | Novavax Plunges 5.85% Pre-market as FDA Misses Deadline on COVID-19 Vaccine Decision

Stock Track
·
03 Apr

Stock Track | Novavax Plunges 5.85% in Pre-market as FDA Misses Key Vaccine Decision Deadline

Stock Track
·
03 Apr

PRESS DIGEST - Wall Street Journal - April 3

Reuters
·
03 Apr

Novavax (NVAX) Stock Sinks As Market Gains: Here's Why

Zacks
·
03 Apr

Health Care Up as Biotech Rebounds -- Health Care Roundup

Dow Jones
·
03 Apr

Update: Novavax Awaits Decision on Full Approval of Covid Vaccine After FDA Misses Deadline

MT Newswires Live
·
03 Apr

BRIEF-Novavax Can Confirm That April 1, Was U.S FDA’S PDUFA Date For BLA Seeking Approval Of Our Covid-19 Vaccine

Reuters
·
03 Apr

Novavax Inc: Have Not yet Received Official Decision From U.S. FDA

THOMSON REUTERS
·
03 Apr

Novavax: Can Confirm That April 1, Was U.S. FDA’s Pdufa Date for Bla Seeking Approval of Our Covid-19 Vaccine - Statement

THOMSON REUTERS
·
03 Apr

Novavax Inc: as of Tuesday, April 1,Believe That Our Bla Is Ready for Approval

THOMSON REUTERS
·
03 Apr

FDA Misses Deadline for Granting Full Approval for Novavax's Covid-19 Vaccine, Sources Say -- Update

Dow Jones
·
03 Apr

Market Chatter: US FDA Misses Deadline for Full Approval of Novavax's Covid-19 Vaccine

MT Newswires Live
·
03 Apr